Secretory leukocyte protease inhibitor (SLPI) as a key factor for cholangiocarcinoma progression

被引：0
|
作者：
Phimsen, Suchada [1 ]
Chueajedton, Kangsadan [1 ]
Chueaiphuk, Chaiwat [1 ]
Jantra, Jeranan [1 ]
Sonsuwan, Anisa [1 ]
Kaewkong, Worasak [1 ]
Kumphune, Sarawut [1 ]
Wongkham, Sopit [1 ,2 ]
机构：
[1] Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok, Thailand
[2] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2067
引用
收藏
页码：1092 / 1092
页数：1
相关论文
共 50 条
  • [41] Expression of secretory leukocyte protease inhibitor (SLPI) in experimental acute cardiac allograft rejection.
    Kelemen, SE
    Autieri, MV
    Mu, AB
    Eisen, HJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 511 - 511
  • [42] Secretory leukocyte protease inhibitor (SLPI) inhibits the production of matrix metalloproteinases (MMP) by monocytes.
    Zhang, Y
    McNeely, T
    Wahl, SM
    Wahl, LM
    FASEB JOURNAL, 1996, 10 (06): : 759 - 759
  • [43] Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris
    Li, Zhiguo
    Moy, Allison
    Sohal, Kirti
    Dam, Carolyn
    Kuo, Peter
    Whittaker, James
    Whittaker, Mei
    Duezguenes, Nejat
    Konopka, Krystyna
    Franz, Andreas H.
    Lin-Cereghino, Joan
    Lin-Cereghino, Geoff P.
    PROTEIN EXPRESSION AND PURIFICATION, 2009, 67 (02) : 175 - 181
  • [44] Secretory leukocyte protease inhibitor (SLPI) is a potent regulator of microbial induced monocyte activation and intestinal inflammation
    Menckeberg, C. L.
    Simons-Oosterhuis, Y.
    Lindenbergh-Kortleve, D. J.
    De Ruiter, L.
    Raatgeep, H. C.
    van Berkel, L. A.
    van Lierop, P. P. E.
    Nieuwenhuis, E. E. S.
    de Ridder, L.
    Escher, J. C.
    Samsom, J. N.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S393 - S393
  • [45] Secretory Leukocyte Protease Inhibitor (SLPI) promotes hepatic resolution responses in acute liver failure (ALF)
    Triantafyllou, Evangelos
    Pop, Oltin T.
    Liaskou, Evaggelia
    Bernsmeier, Christine
    Khamri, Wafa
    Stamataki, Zania
    Ma, Yun
    Thursz, Mark R.
    Wendon, Julia
    Quaglia, Alberto
    Weston, Chris J.
    Curbishley, Stuart M.
    Adams, David H.
    Antoniades, Charalambos G.
    HEPATOLOGY, 2014, 60 : 560A - 560A
  • [46] Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation
    Westin, U
    Polling, Å
    Ljungkrantz, I
    Ohlsson, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (04) : 489 - 493
  • [47] Concordant expression of secretory leukocyte protease inhibitor (SLPI) in colonic tissue of IBD and animal models of colitis
    Prouty, Stephen M.
    Mabus, John R.
    Smith, Cynthia
    Kimball, Edward S.
    Schneider, Craig R.
    Wallace, Nathaniel H.
    Wade, Paul R.
    Towers, Meghan
    Ilyin, Sergey
    D'Andrea, Michael
    Bittner, Anton
    Carmen, Andrew
    Amaratunga, Dhammika
    Go, Oscar
    Hornby, Pamela J.
    GASTROENTEROLOGY, 2006, 130 (04) : A699 - A699
  • [48] Analysis of secretory leukocyte protease inhibitor (SLPI) concentrations and neutrophil functions in children after cardiopulmonary bypass
    Pasnik, Jarek
    Moll, Jadwiga A.
    Pokoca, Lech T.
    Moll, Jacek
    Arendarczyk, Jerzy
    Mazurowski, Wojciech W.
    Sysa, Andrzej
    Zeman, Krzysztof
    INFLAMMATION RESEARCH, 2005, 54 : S204 - S204
  • [49] Effect pf mutant forms of secretory leukocyte protease inhibitor (SLPI) on guinea pig airway hyperresponsiveness
    Middleton, SC
    Wright, CD
    Havill, AM
    FASEB JOURNAL, 2001, 15 (05): : A1016 - A1016
  • [50] Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
    Sayers, Kevin T.
    Brooks, Alan D.
    Sayers, Thomas J.
    Chertov, Oleg
    PLOS ONE, 2014, 9 (08):
12345